GlassScriptPhysician profile
Richard L Meyer
NPI 1588664718
$15,687.65
in general payments reported to CMS, 2019-2025
21 companies · $382 in 2025
The $382 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,343 · 2020: $1,238 · 2021: $595 · 2022: $4,190 · 2023: $364 · 2024: $576 · 2025: $382.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,290 · Travel and Lodging: $31.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,289.64 |
| Travel and Lodging | $31.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $10,155.74 | 2019-2022 | |
| Stryker Corporation | $3,124.03 | 2019-2025 | Mako, Aequalis Flex Revive |
| Alon Medical Technology | $1,026.97 | 2020 | |
| Depuy Synthes Sales INC. | $491.16 | 2021-2024 | |
| Davol INC. | $167.01 | 2022-2023 | Channel Drain |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $107.42 | 2019 | |
| Horizon Therapeutics Plc | $96.13 | 2019-2022 | |
| Conmed Corporation | $94.16 | 2019 | |
| Heron Therapeutics, INC. | $84.48 | 2024-2025 | Zynrelef |
| Medtronic, INC. | $54.33 | 2021-2025 | Aquamantys(Tm) |
| Bioventus LLC | $51.17 | 2019-2025 | Xcell, Gelsyn-3 |
| Fidia Pharma USA INC. | $40.07 | 2020-2022 | |
| Pacira Pharmaceuticals Incorporated | $33.20 | 2023-2024 | Exparel, Iovera, Zilretta |
| Pacira Therapeutics, INC. | $29.16 | 2020 | |
| Ethicon US, LLC | $27.61 | 2019-2021 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $27.51 | 2019 | |
| Convatec INC. | $24.56 | 2022 | |
| Smith+Nephew, INC. | $17.93 | 2024 | Pico 14 |
| Vertex Pharmaceuticals Incorporated | $16.00 | 2025 | |
| Ferring Pharmaceuticals INC. | $12.13 | 2019 | |
| Sonex Health, INC. | $6.88 | 2024 | Sx-One Microknife |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Meyer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.